Maria Sharapova shoots down question over banned drug meldonium

The drugs controversy that led to a 15-month ban for Maria Sharapova has flared again after the Russian star was quizzed about meldonium following her loss to Ash Barty at the Australian Open.

Maria Sharapova at the Australian Open. Pic: Michael Klein

Maria Sharapova has refused to discuss the impact of being unable to take meldonium after her fourth round exit at the Australian Open.

The Russian was sensationally suspended from tennis after testing positive to the drug, which was added to the WADA banned list on January 1, 2016.

UNDER FIRE: SHARAPOVA BLASTED OVER BATHROOM BREAK

LOUD: WHAT HAPPENED TO PLAN TO SILENCE SHRIEKERS?

SEXISM ROW: COACH SAYS MALE PLAYERS ‘STONGER, TOUGHER’

Sharapova tested positive at the Australian Open in 2016. She served a 15-month ban for the use of the drug.

When asked today about the impact that having to find new medication to treat her medical conditions has had on her ability to compete in tough grand slam events, Sharapova said: “Is there another question?”

Sharapova claimed at the time of the positive drug test she had taken the drug for 10 years because of a magnesium deficiency and family history of diabetes.

She said she had neglected to read an email informing her of the new banned drugs list, which led to her use of meldonium at the Australian Open.

Sharapova lost her fourth-round match against Australia’s Ash Barty 4-6 6-1 6-4.

Originally published as Maria Sharapova shoots down question over banned drug meldonium